Jun Lin
Zhejiang Chinese Medical University(CN)Fujian Medical University(CN)Sun Yat-sen University(CN)The University of Melbourne(AU)Guilin Medical University(CN)Beijing University of Chinese Medicine(CN)Shanghai Jiao Tong University(CN)Gold Coast Hospital(AU)China South Industries Group (China)(CN)Wuhan University(CN)Soochow University(CN)Xinjiang Uygur Autonomous Region Disease Prevention and Control Center(CN)Hubei Provincial Center for Disease Control and Prevention(CN)Xinjiang Entry-Exit Inspection and Quarantine Bureau(CN)Zhongnan Hospital of Wuhan University(CN)Second Affiliated Hospital of Fujian Medical University(CN)Shanghai First People's Hospital(CN)Third Affiliated Hospital of Sun Yat-sen University(CN)Shenzhen Institute for Drug Control(CN)Jinhua Central Hospital(CN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Gastric Cancer Management and Outcomes, Long-Term Effects of COVID-19
Most-Cited Works
- → Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19(2020)1,181 cited
- → Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial(2020)1,054 cited
- → Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China(2020)446 cited
- → Mitochondrial DNA Content: Its Genetic Heritability and Association With Renal Cell Carcinoma(2008)266 cited
- → Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID‐19 patients(2020)233 cited
- → Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma(2010)205 cited